Literature DB >> 10567721

Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease.

M Yanagisawa1, E Planel, K Ishiguro, S C Fujita.   

Abstract

Hyperphosphorylated tau is the major component of paired helical filaments in neurofibrillary tangles found in Alzheimer's disease brains, and tau hyperphosphorylation is thought to be a critical event in the pathogenesis of this disease. The objective of this study was to reproduce tau hyperphosphorylation in an animal model by inducing hypoglycemia. Food deprivation of mice for 1 to 3 days progressively enhanced tau hyperphosphorylation in the hippocampus, to a lesser extent in the cerebral cortex, but the effect was least in the cerebellum, in correspondence with the regional selectivity of tauopathy in Alzheimer's disease. This hyperphosphorylation was reversible by refeeding for 1 day. We discuss possible mechanisms of this phenomenon, and propose the starved mouse as a simple model to study in vivo tau phosphorylation and dephosphorylation which are altered in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567721     DOI: 10.1016/s0014-5793(99)01480-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.

Authors:  Laetitia Troquier; Raphaelle Caillierez; Sylvie Burnouf; Francisco J Fernandez-Gomez; Marie-Eve Grosjean; Nadege Zommer; Nicolas Sergeant; Susanna Schraen-Maschke; David Blum; Luc Buee
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

2.  Solution structure of the kinase-associated domain 1 of mouse microtubule-associated protein/microtubule affinity-regulating kinase 3.

Authors:  Naoya Tochio; Seizo Koshiba; Naohiro Kobayashi; Makoto Inoue; Takashi Yabuki; Masaaki Aoki; Eiko Seki; Takayoshi Matsuda; Yasuko Tomo; Yoko Motoda; Atsuo Kobayashi; Akiko Tanaka; Yoshihide Hayashizaki; Takaho Terada; Mikako Shirouzu; Takanori Kigawa; Shigeyuki Yokoyama
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

Review 3.  Alzheimer's disease pathologic cascades: who comes first, what drives what.

Authors:  Russell H Swerdlow
Journal:  Neurotox Res       Date:  2011-09-13       Impact factor: 3.911

4.  Increased tau phosphorylation and aggregation in the hippocampus of mice overexpressing corticotropin-releasing factor.

Authors:  Shannon N Campbell; Cheng Zhang; Louise Monte; Allyson D Roe; Kenner C Rice; Yvette Taché; Eliezer Masliah; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Do RCAN1 proteins link chronic stress with neurodegeneration?

Authors:  Gennady Ermak; Melanie A Pritchard; Sladjana Dronjak; Brenda Niu; Kelvin J A Davies
Journal:  FASEB J       Date:  2011-06-16       Impact factor: 5.191

Review 6.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

Review 7.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 8.  Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.

Authors:  C-X Gong; K Iqbal
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  CaM kinase II isoforms are expressed at lower levels in brains of shiverer mutants.

Authors:  Christopher T Suznovich; Rongsun Pu; Allan J Bieber
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

10.  Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation.

Authors:  Robert A Rissman; Kuo-Fen Lee; Wylie Vale; Paul E Sawchenko
Journal:  J Neurosci       Date:  2007-06-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.